ArticleBMC ophthalmology2024

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema.

Rishi P Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.